PEBP1 and neoplasm: RKIP further appears to counteract tumor resistance to chemotherapy, immunotherapy, and radiotherapy, while enhancing anticancer host immunosurveillance [11] via direct suppression of the aforementioned signaling pathways [11,12,16,17].